OM Pharma Ltd. products

Dicynone (etamsylate) is used for the prevention and treatment of capillary haemorrhages of different origin such as heavy menstrual bleeding (menorrhagia), metrorrhagia, surgery affecting highly vascularised tissues, epistaxis and periventricular haemorrhage in new-borns.

Uro-Vaxom is an extract of various strains of Escherichia coli for the treatment and prevention of recurrent urinary tract infections. It stimulates the immune system and the body’s natural defense against urinary pathogens.

Doxium (calcium dobesilate) is used for the oral treatment of microangiopathies (e.g. diabetic retinopathy), signs of chronic venous insufficiency in the lower limbs (pain, cramps, paraesthesia, oedema, stasis dermatosis) and haemorrhoidal syndrome.

Broncho-Vaxom, an extract of several different bacterial species, is indicated in the prevention of recurrent respiratory tract infections for both adults and children. Administered orally, it modulates the immune system to help defend against respiratory pathogens.

Doxiproct (calcium dobesilate and lidocaine hydrochloride) and DoxiproctPlus (calcium dobesilate, lidocaine hydrochloride and dexamethasone acetate) are topical forms used for the local treatment of haemorrhoidal syndrome (incl. pre- and postoperative treatment in cases of hemorrhoidectomy)